tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
388 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is -0.19, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 13.46, while ARS Pharmaceuticals’s (SPRY) share price is $12.2, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 13.24, while ARS Pharmaceuticals’s (SPRY) share price is $12.2, making it a Sell.

ARS Pharmaceuticals (SPRY) Pivot Points

May 16, 2025, 05:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.39
11.09
11.60
12.30
12.81
13.51
14.02
Fibonacci
11.09
11.56
11.84
12.30
12.77
13.05
13.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

May 16, 2025, 05:30 PM
Period
Simple
Exponential
MA5
12.88Sell
12.75Sell
MA10
13.41Sell
13.18Sell
MA20
13.86Sell
13.46Sell
MA50
13.14Sell
13.24Sell
MA100
12.49Sell
12.93Sell
MA200
13.05Sell
12.57Sell
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 13.18, while ARS Pharmaceuticals’s (SPRY) share price is $12.2, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 12.93, while ARS Pharmaceuticals’s (SPRY) share price is $12.2, making it a Sell.
ARS Pharmaceuticals’s (SPRY) stock price is $12.2 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 13.14, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $12.2 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 12.49, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $12.2 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 13.05, creating a Sell signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

May 16, 2025, 05:30 PM
Name
Value
Implied Action
RSI (14)
36.07
Neutral
STOCH (9,6)
16.20
Buy
STOCHRSI (14)
14.79
Buy
MACD (12,26)
-0.19
Buy
ADX (14)
21.54
Neutral
Williams %R
-83.85
Buy
CCI (14)
-214.16
Buy
ATR (14)
0.83
-
Ultimate Oscillator
45.09
Neutral
ROC
-11.40
Sell
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 36.07, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 21.54, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is -214.16, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is -11.40, creating a Sell signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Sell.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 36.07, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is -0.19, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 12.88, which suggests SPRY is a Sell.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 13.86, which suggests SPRY is a Sell.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 13.14, which suggests SPRY is a Sell.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 13.05, which suggests SPRY is a Sell.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -83.85, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is -214.16, which suggests SPRY is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis